Sign in

You're signed outSign in or to get full access.

Joanne Medero

About Joanne T. Medero

Independent Board Member of Nuveen Select Maturities Municipal Fund (NIM); born 1954; joined the Nuveen Funds Board in 2021; currently serves as a Class II or III Board Member with term expiring at the 2027 annual meeting. Career spans 30+ years in financial services and public policy, including senior roles at BlackRock, Barclays Global Investors, and as General Counsel of the CFTC; BA St. Lawrence University (1975), JD George Washington University Law School (1978). Oversees 217 portfolios across the Nuveen/TIAA fund complex; classified as an Independent Board Member (not an “interested person”). Attendance in the last fiscal year met or exceeded 75% for Board and committee meetings.

Past Roles

OrganizationRoleTenureCommittees/Impact
Commodity Futures Trading Commission (CFTC)General Counsel1989–1993Led derivatives market regulation legal function; member CFTC Global Markets Advisory Committee (2006–2010)
The White House, Office of Presidential PersonnelDeputy Associate Director/Associate Director for Legal and Financial Affairs1986–1989Senior legal and financial advisory responsibilities
Orrick, Herrington & Sutcliffe LLPPartner (Derivatives & Financial Markets Regulation)1993–1995Specialized in derivatives and market regulation
Barclays Global Investors (BGI)Managing Director; Global General Counsel & Corporate Secretary1996–2006Global legal leadership for investment management
Barclays Group (IBIM)Managing Director; Global Head of Government Relations & Public Policy2006–2009Directed legislative/regulatory advocacy for IB, IM, wealth businesses
BlackRock, Inc.Managing Director, Government Relations & Public Policy; Senior Advisor to Vice Chairman2009–2020; 2018–2020Corporate governance and public policy advisory

External Roles

OrganizationRoleTenureCommittees/Impact
Baltic-American Freedom FoundationDirectorSince 2019Education/professional exchanges for Baltic states
SIFMA Asset Management GroupSteering Committee Chair2016–2018Industry policy leadership
Managed Funds AssociationChair, CTA/CPO & Futures Committee2010–2012Derivatives/commodity fund policy
The Federalist SocietyChair, Corporations/Antitrust/Securities Practice Group2010–2022; 2000–2002Legal policy leadership

Board Governance

  • Independence: All current Board Members (including Medero) are not “interested persons” of the Funds or Adviser; deemed Independent Board Members.
  • Years of service: Since 2021; Class II or III term expires at 2027 annual meeting.
  • Portfolios overseen: 217.
  • Committee memberships (Nuveen Funds):
    • Compliance, Risk Management & Regulatory Oversight Committee (member; Chair is Wolff).
    • Nominating & Governance Committee (member; Chair is Young).
    • Investment Committee (member; Co-Chairs Boateng and Lancellotta).
  • Audit Committee: Not a member (members are Nelson [Chair], Boateng, Lancellotta, Starr, Thornton, Wolff, Young).
  • Attendance: Each Board Member attended ≥75% of Board and relevant committee meetings in the last fiscal year.
  • Meeting cadence (Select Maturities/NIM – last fiscal year): 4 Regular Board; 7 Special Board; 3 Executive; 8 Dividend; 4 Compliance; 14 Audit; 6 Nominating & Governance; 4 Investment; 4 Closed-End Fund.

Fixed Compensation

  • Structure (effective Jan 1, 2025; Independent Board Members):
    • Annual base retainer: $350,000.
    • Committee membership retainers: Audit $35,000; Compliance $35,000; Investment $30,000; Dividend $25,000; Nominating & Governance $25,000; Closed-End Funds $25,000.
    • Committee chair retainers: Audit $35,000; Compliance $35,000; Investment $30,000; Dividend/Nominating/Closed-End $25,000; Board Chair $150,000.
    • Ad hoc meeting fees: $1,000 or $2,500 depending on length/immediacy.
    • Deferred Compensation Plan available (deferrals mirror investments in eligible Nuveen funds).
ComponentAmount (USD)Applicability to MederoCitation
Base retainer$350,000Yes (Independent Director)
Compliance Committee membership$35,000Member
Nominating & Governance Committee membership$25,000Member
Investment Committee membership$30,000Member
Ad hoc meeting fees$1,000–$2,500 per meetingAs applicable
Deferred Compensation PlanElected amountsAvailable; balances by fund disclosed
  • Actual aggregate compensation paid across Nuveen Funds (latest disclosed): Medero $461,987.
FundPeriodAggregate Compensation Paid to Medero (USD)
Nuveen Select Maturities Municipal Fund (NIM)Fiscal year ended Mar 31, 2025$330
Total from Nuveen FundsLatest disclosed$461,987

Performance Compensation

ElementStatusNotes
Cash bonus (target/actual)Not disclosed/Not applicableDirector pay is retainer- and meeting-based; no bonus metrics disclosed.
Equity awards (RSUs/PSUs)Not applicableNuveen funds have no employees; directors receive no stock awards; deferrals mirror fund investments.
OptionsNot applicableNo option awards disclosed for directors.
Performance metrics (TSR, EBITDA, ESG)Not applicableNo performance-linked compensation metrics disclosed for directors.

Other Directorships & Interlocks

Company/OrganizationTypeRoleTenurePotential Interlock/Conflict
Baltic-American Freedom FoundationNon-profitDirectorSince 2019None disclosed vis-à-vis NIM.
Public company boardsNone disclosedNone.
  • Independence statement: Board members (incl. Medero) have never been employees/directors of TIAA/Nuveen or affiliates; deemed Independent.
  • Related-party exposures: Table of holdings in entities under common control lists Kenny; no Medero entries.

Expertise & Qualifications

  • Regulatory/governance expertise: Former CFTC General Counsel; leadership in industry bodies (SIFMA AMG; MFA committees; Federalist Society practice group).
  • Corporate governance and public policy: Senior Advisor to BlackRock Vice Chairman; led government relations/public policy at BlackRock and Barclays.
  • Legal credentials: JD (GWU Law); former global general counsel at BGI; derivatives/market regulation specialist.
  • Portfolio oversight breadth: Oversees 217 portfolios in Nuveen/TIAA fund complex.

Equity Ownership

  • Ownership alignment guideline: Board expects each member to invest at least the equivalent of one year of compensation in funds in the Fund Complex (directly or deferred).
MeasureNIM (Select Maturities)Fund Complex Aggregate
Dollar range of equity securities$0 Over $100,000
Shares beneficially owned0 Not itemized (aggregate range above)
Ownership as % of NIM shares outstanding0.00% (0 of 12,446,597)
Pledged sharesNone disclosed
Section 16(a) filingsCompliant; no delinquencies noted

Note: Aggregate “Over $100,000” is a coarse range and does not indicate whether the one-year compensation guideline is fully met; deferred compensation balances by fund are disclosed separately.

Governance Assessment

  • Strengths:

    • Independence affirmed; no affiliation with TIAA/Nuveen; broad regulatory/governance expertise (CFTC GC, BlackRock/Barclays policy leadership).
    • Active committee participation (Compliance; Nominating & Governance; Investment) aligned with skillset; Board-wide attendance ≥75%.
    • Transparent, structured director pay with disclosed retainers; availability of deferred plan to align economic interests with fund shareholders.
    • No related-party transactions or pledging disclosed for Medero; Section 16 compliance noted.
  • Watch items:

    • No performance-linked components (typical for fund directors), which places alignment emphasis on holdings/deferred balances rather than pay-at-risk signals.
    • Aggregate equity ownership range “Over $100,000” vs. total compensation ($461,987) suggests partial alignment; exact compliance with “one-year compensation” guideline cannot be confirmed due to range reporting.
  • Overall implication for investor confidence: Governance profile is solid—independent status, relevant committee roles, and strong regulatory background support board effectiveness. Lack of performance pay is standard for closed-end funds; alignment rests on the investment expectation and deferred plan participation; no conflicts or red flags disclosed specific to Medero.